1 in 8 people over 75 years old suffer
from a valvular heart disease (VHD).
Aortic insufficiency is the third most common VHD.
There are three ways to treat aortic insufficiency:
In mild cIases this condition is treated by medications.
Surgical aortic valve replacement
Until recently, surgical aortic valve replacement was the standard of care in adults with severe symptomatic aortic insufficiency. This procedure has a high risk of complications, which can lead to death. In addition hospitalization and recovery are long.
Percutaneous aortic valve replacement (TAVI)
Percutaneous aortic valve replacement (TAVI) is the replacement of the aortic valve of the heart through the blood vessels and has lower peri- and early post-procedural complication rates in patients.
TAVI is not applicable to all relevant patients: if there is no calcification of the arteries it is impossible to connect the replacement valve. The closure might be insufficient and there is a risk of paravalvular leak, which may lead to failure of the heart.